New Risk • Mar 25
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of South Korean stocks, typically moving 16% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (16% average weekly change). Earnings have declined by 29% per year over the past 5 years. New Risk • Mar 24
New minor risk - Market cap size The company's market capitalization is less than US$100m. Market cap: ₩145.0b (US$96.9m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 29% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (13% average weekly change). Market cap is less than US$100m (₩145.0b market cap, or US$96.9m). Announcement • Mar 17
JOONGANG ADVANCED MATERIALS Co., Ltd., Annual General Meeting, Mar 31, 2026 JOONGANG ADVANCED MATERIALS Co., Ltd., Annual General Meeting, Mar 31, 2026, at 09:30 Tokyo Standard Time. Location: seminar room, 25, simin-daero 248beon-gil, dongan-gu, gyeonggi-do, anyang South Korea Announcement • Jan 07
Enchem Co., Ltd. (KOSDAQ:A348370) completed the acquisition of an additional 5.27% stake in JOONGANG ADVANCED MATERIALS Co., Ltd. (KOSDAQ:A051980) from Atlas8000 Co., Ltd. Enchem Co., Ltd. (KOSDAQ:A348370) signed a contract to acquire 5.3% stake in JOONGANG ADVANCED MATERIALS Co., Ltd. (KOSDAQ:A051980) from Atlas8000 Co., Ltd. for KRW 15.7 billion on December 26, 2025. A cash consideration of KRW 15.7 billion valued at KRW 2684 per share will be paid by Enchem for 5,850,320 shares.
The expected completion of the transaction is January 5, 2026.
Enchem Co., Ltd. (KOSDAQ:A348370) completed the acquisition of an additional 5.27% stake in JOONGANG ADVANCED MATERIALS Co., Ltd. (KOSDAQ:A051980) from Atlas8000 Co., Ltd. on January 5, 2026. Before completion, Enchem Co., Ltd. owns 9.26% stake in JOONGANG ADVANCED MATERIALS Co., Ltd. After completion, Enchem Co., Ltd. owns 14.53% stake in JOONGANG ADVANCED MATERIALS Co., Ltd. Announcement • Sep 10
JOONGANG ADVANCED MATERIALS Co., Ltd. announced that it has received KRW 9.49999419 billion in funding from Kwangmu Co.,Ltd. On September 8, 2025, JOONGANG ADVANCED MATERIALS Co., Ltd. closed the transaction. Buy Or Sell Opportunity • Jul 25
Now 22% undervalued after recent price drop Over the last 90 days, the stock has fallen 27% to ₩3,385. The fair value is estimated to be ₩4,317, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 6.6% over the last 3 years. Earnings per share has declined by 16%. Announcement • May 30
SJ Cheil Private Equity Partnership completed the acquisition of 16.59% stake in INITECH Co., Ltd (KOSDAQ:A053350) from JOONGANG ADVANCED MATERIALS Co., Ltd. (KOSDAQ:A051980). SJ Cheil Private Equity Partnership agreed to acquire 16.59% stake in INITECH Co., Ltd (KOSDAQ:A053350) from JOONGANG ADVANCED MATERIALS Co., Ltd. (KOSDAQ:A051980) for KRW 26.3 billion on May 28, 2025. As part of the acquisition, SJ Cheil Private Equity Partnership through its investment purpose company SJ 2nd Holdings Co., Ltd. will acquire 3.3 million shares in INITECH Co., Ltd. As part of consideration, KRW 10 billion will be paid on signing of contract and the remaining KRW 16.3 billion will be paid upon completion. The expected completion of the transaction is May 29, 2025.
SJ Cheil Private Equity Partnership completed the acquisition of 16.59% stake in INITECH Co., Ltd (KOSDAQ:A053350) from JOONGANG ADVANCED MATERIALS Co., Ltd. (KOSDAQ:A051980) on May 29, 2025. Announcement • May 29
SJ Cheil Private Equity Partnership agreed to acquire 16.59% stake in INITECH Co., Ltd (KOSDAQ:A053350) from JOONGANG ADVANCED MATERIALS Co., Ltd. (KOSDAQ:A051980) for KRW 26.3 billion. SJ Cheil Private Equity Partnership agreed to acquire 16.59% stake in INITECH Co., Ltd (KOSDAQ:A053350) from JOONGANG ADVANCED MATERIALS Co., Ltd. (KOSDAQ:A051980) for KRW 26.3 billion on May 28, 2025. As part of the acquisition, SJ Cheil Private Equity Partnership through its investment purpose company SJ 2nd Holdings Co., Ltd. will acquire 3.3 million shares in INITECH Co., Ltd. As part of consideration, KRW 10 billion will be paid on signing of contract and the remaining KRW 16.3 billion will be paid upon completion. The expected completion of the transaction is May 29, 2025. Announcement • Apr 16
JOONGANG ADVANCED MATERIALS Co., Ltd. announced that it expects to receive KRW 9.9997032 billion in funding JOONGANG ADVANCED MATERIALS Co., Ltd. announced a private placement to issue 2,759,300 common shares at an issue price of KRW 3,624 per share for gross proceeds of KRW 9,999,703,200 on April 14, 2025. The transaction will include participation from new investors Avenir Partners Co., Ltd. 1.931,500 shares, Seon Dae In 413,900 shares and Kim Taehyun for 413,900 shares The transaction has been approved by shareholders, expected to close on May 15, 2025 and restricted to a hold period. New Risk • Apr 15
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of South Korean stocks, typically moving 13% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (13% average weekly change). Earnings have declined by 46% per year over the past 5 years. Minor Risk Shareholders have been diluted in the past year (30% increase in shares outstanding). Announcement • Apr 08
Kwangmu Co.,Ltd. (KOSDAQ:A029480) completed the acquisition of an additional 4.6% stake in JOONGANG ADVANCED MATERIALS Co., Ltd (KOSDAQ:A051980) from Atlas8000 Co., Ltd. Kwangmu Co.,Ltd. (KOSDAQ:A029480) agreed to acquire an additional 4.6% stake in JOONGANG ADVANCED MATERIALS Co., Ltd (KOSDAQ:A051980) from Atlas8000 Co., Ltd. for KRW 15 billion on March 7, 2025. A cash consideration of KRW 15 billion will be paid by Kwangmu for 4.658386 million shares. The transaction will be financed through equity investment of KRW 15 billion.
The expected completion of the transaction is April 7, 2025. As of April 4, 2025, Atlas8000 and Kwangmu have entered into a stock purchase agreement amendment contract on April 4, 2025 to change the number of shares to be traded from 3,28 million to 4.66 million in the stock purchase agreement signed on March 7, 2025. The sale of 3,28 million shares have concluded on April 7, 2025, at the same time as payment.
Kwangmu Co.,Ltd. (KOSDAQ:A029480) completed the acquisition of an additional 4.6% stake in JOONGANG ADVANCED MATERIALS Co., Ltd (KOSDAQ:A051980) from Atlas8000 Co., Ltd. on April 7, 2025. Announcement • Mar 18
JOONGANG ADVANCED MATERIALS Co., Ltd, Annual General Meeting, Mar 31, 2025 JOONGANG ADVANCED MATERIALS Co., Ltd, Annual General Meeting, Mar 31, 2025, at 10:00 Tokyo Standard Time. Location: conference room, 126, beolmal-ro, dongan-gu, gyeonggi-do, anyang South Korea New Risk • Dec 07
New major risk - Financial data availability The company's latest financial reports are more than a year old. Last reported fiscal period ended September 2013. This is considered a major risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. In the worst case scenario, it may be facing other major going concern issues jeopardizing its viability as a listed company. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported September 2013 fiscal period end). Share price has been highly volatile over the past 3 months (12% average weekly change). Minor Risk Shareholders have been diluted in the past year (27% increase in shares outstanding). New Risk • Dec 03
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of South Korean stocks, typically moving 12% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (12% average weekly change). Earnings have declined by 46% per year over the past 5 years. Minor Risk Shareholders have been diluted in the past year (27% increase in shares outstanding). New Risk • Sep 17
New major risk - Financial data availability The company has not reported any financial data. This is considered a major risk. With no or incomplete audited reported financial data, it is virtually impossible to assess the company's investment potential. Currently, the following risks have been identified for the company: Major Risk No financial data reported. Minor Risks Share price has been volatile over the past 3 months (10% average weekly change). Shareholders have been diluted in the past year (27% increase in shares outstanding). New Risk • Oct 24
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of South Korean stocks, typically moving 13% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (13% average weekly change). Negative equity (-₩26b). Earnings have declined by 56% per year over the past 5 years. Shareholders have been substantially diluted in the past year (115% increase in shares outstanding). New Risk • Sep 01
New major risk - Negative shareholders equity The company has negative equity. Total equity: -₩26b This is considered a major risk. Being in negative equity means that the company's liabilities exceed its assets, meaning it owes more to creditors than it has in owned assets. While this doesn't mean the company is about to collapse, in the long-term, this is unsustainable. The company may have issues meeting financial obligations, is at risk of becoming insolvent and may have difficulty raising capital, especially more debt, if needed. Currently, the following risks have been identified for the company: Major Risks Negative equity (-₩26b). Earnings have declined by 56% per year over the past 5 years. Shareholders have been substantially diluted in the past year (110% increase in shares outstanding). Minor Risk Share price has been volatile over the past 3 months (10% average weekly change). Announcement • Jun 23
JOONGANG DNM Co.,Ltd announced that it has received KRW 19.9975 billion in funding from Kwangmu Co.,Ltd. On June 22, 2023, JOONGANG DNM Co.,Ltd closed the transaction of series 13 bonds. Announcement • Jun 21
JOONGANG DNM Co.,Ltd announced that it expects to receive KRW 22 billion in funding from Enchem Co., Ltd. JOONGANG DNM Co.,Ltd announced a private placement of series 14 non-guaranteed private placement convertible bond for gross proceeds of KRW 22,000,000,000 on June 20, 2023. The transaction will include participation from new investor, Enchem Co., Ltd. The bonds will be issued at par and do not carry any coupon. The bonds have yield to maturity of 0% and would mature on July 7, 2026. The bonds will be fully convertible into 4,712,939 shares of the company at a fixed conversion price of KRW 4,668 from July 7, 2024 and June 7, 2026. The bonds are redeemable. The subscription date is June 20, 2023. The payment date is July 7, 2023. The transaction has been approved by its board of directors. Announcement • Feb 16
JOONGANG DNM Co.,Ltd announced that it expects to receive KRW 4.9997 billion in funding from GP Club Co., Ltd. JOONGANG DNM Co.,Ltd announced a private placement 2,890,000 shares at issue price of KRW 1,730 per share for a gross proceeds of KRW 4,999,700,000 on February 15, 2023. The transaction will include participation from new investor, GP Club Co., Ltd. for 2,890,000 shares. The company issued shares through third party allocation method. The transaction is expected to close on March 27, 2023. The transaction has been approved by the board of directors. Announcement • Jan 12
JOONGANG DNM Co.,Ltd announced that it has received KRW 5 billion in funding from HF Networks Co., Ltd. On January 12, 2023, JOONGANG DNM Co.,Ltd closed the transaction. Board Change • Nov 16
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. No highly experienced directors. 1 independent director (3 non-independent directors). CEO & Representative Director Incheol Jeong was the last director to join the board, commencing their role in 2017. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Announcement • Sep 07
JOONGANG DNM Co.,Ltd has completed a Follow-on Equity Offering in the amount of KRW 999.9995 million. JOONGANG DNM Co.,Ltd has completed a Follow-on Equity Offering in the amount of KRW 999.9995 million.
Security Name: Common Stock
Security Type: Common Stock
Securities Offered: 1,999,999
Price\Range: KRW 500 Board Change • May 10
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. No highly experienced directors. 1 independent director (3 non-independent directors). CEO & Representative Director Incheol Jeong was the last director to join the board, commencing their role in 2017. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Reported Earnings • Apr 03
Full year 2021 earnings released: ₩234 loss per share (vs ₩252 loss in FY 2020) Full year 2021 results: ₩234 loss per share. Revenue: ₩13.0b (up 21% from FY 2020). Net loss: ₩17.2b (loss widened 42% from FY 2020). Announcement • Feb 04
JOONGANG DNM Co.,Ltd announced that it expects to receive KRW 20 billion in funding from Caelum Partners Co., Ltd. and another investor JOONGANG DNM Co.,Ltd announced a private placement of series 10 unregistered coupon nonguaranteed private convertible bond for gross proceeds of KRW 15,000,000,000 and series 11 unregistered coupon nonguaranteed private convertible bond for gross proceeds of KRW 5,000,000,000; for aggregate gross proceeds of KRW 20,000,000,000 on February 3, 2022. The series 10 bonds will include participation from new investor Geoyeon Holdings and series 11 bonds will include participation from Caelum Partners Co., Ltd. The bonds carry a rate coupon rate of 3% and Interest rate of 3%. The series 10 bonds will mature on February 25, 2025 and series 11 bonds will mature on April 29, 2025. The series 10 bonds are 100% convertible into 24,834,437 common shares of the company at a fixed conversion price of KRW 604 per share and series 11 bonds are 100% convertible into 8,278,145 common shares of the company at a fixed conversion price of KRW 604 per share. The conversion period for series 10 bonds will start from February 25, 2023 and will end on January 25, 2025 and the conversion period of the series 11 bonds will start on April 29, 2023 and will end on March 29, 2025. The transaction has been approved by the board of directors of the company. The series 10 bonds is expected to close on February 25, 2022 and the series 11 bonds is expected to close on April 29, 2022. All securities issued in the transaction have a hold period of one year. Announcement • Apr 01
CentralBio Co., Ltd. announced that it has received KRW 6.26 billion in funding from HF Networks Co., Ltd. On March 30, 2021, CentralBio Co., Ltd. (KOSDAQ:A051980) closed the transaction. The investor has acquired 14.31% stakes in the company. Is New 90 Day High Low • Feb 18
New 90-day low: ₩1,580 The company is down 14% from its price of ₩1,840 on 20 November 2020. The South Korean market is up 22% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Communications industry, which is up 12% over the same period. Is New 90 Day High Low • Jan 05
New 90-day high: ₩3,140 The company is up 74% from its price of ₩1,800 on 07 October 2020. The South Korean market is up 23% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Communications industry, which is up 6.0% over the same period. Is New 90 Day High Low • Dec 14
New 90-day high: ₩2,170 The company is up 32% from its price of ₩1,650 on 15 September 2020. The South Korean market is up 13% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Communications industry, which is down 8.0% over the same period. Announcement • Oct 29
CentralBio Co., Ltd announced that it has received KRW 13.1 billion in funding from Prime No. 1 Fund On October 28, 2020, CentralBio Co., Ltd (KOSDAQ:A051980) closed the transaction. The company issued bonds of KRW 13,100,000,000 in the transaction. The bonds shall be convertible into 18,821,839 shares of the company. Is New 90 Day High Low • Oct 12
New 90-day high: ₩1,995 The company is up 176% from its price of ₩723 on 14 July 2020. The South Korean market is up 10.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Communications industry, which is up 14% over the same period. Announcement • Oct 08
An unknown buyer acquired 10.1% stake in CentralBio Co., Ltd (KOSDAQ:A051980) from Data Core ZenHealth Co., Ltd for KRW 4.5 billion. An unknown buyer acquired 10.1% stake in CentralBio Co., Ltd (KOSDAQ:A051980) from Data Core ZenHealth Co., Ltd for KRW 4.5 billion on September 8, 2020. Under the terms of transaction, Data Core ZenHealth sold 4.69 million shares at price of KRW 961 per share.
An unknown buyer completed the acquisition of 10.1% stake in CentralBio Co., Ltd (KOSDAQ:A051980) from Data Core ZenHealth Co., Ltd on September 8, 2020. Announcement • Sep 18
HJH Holdings Co., Ltd. and Aview Global Co., Ltd. agreed to acquire 16.15% stake in Barun Technology Co.,Ltd. (KOSDAQ:A029480) from CentralBio Co., Ltd (KOSDAQ:A051980) for KRW 6 billion. HJH Holdings Co., Ltd. and Aview Global Co., Ltd. agreed to acquire 16.15% stake in Barun Technology Co.,Ltd. (KOSDAQ:A029480) from CentralBio Co., Ltd (KOSDAQ:A051980) for KRW 6 billion on August 14, 2020. Aview Global and HJH Holdings will purchase 6 million and 4 million shares, representing total as 16.15% stake in Barun Technology at KRW 600 per share. The consideration will be paid as, KRW 0.6 million as down payment until August 14, 2020, KRW 1.2 billion as intermediate payment until August 24, 2020 and the balance payment of KRW 4.2 billion until September 14, 2020. The Board of Directors of CentralBio resolved the transaction. The transaction is expected to close on September 14, 2020. Jung Hyeon Accounting Corporation acted as external evaluation agency in the deal. Announcement • Aug 19
CentralBio Co., Ltd announced that it expects to receive KRW 6.26 billion in funding from TYECO Co., Ltd. CentralBio Co., Ltd (KOSDAQ:A051980) announced a private placement of 10,000,000 common shares at a price of KRW 626 for gross proceeds of KRW 6,260,000,000 on August 18, 2020. The transaction will include participation from returning investor TYECO Co., Ltd. The shares have a face value of KRW 500 per share and a lock-up period of 1 year. The company will issue shares on third party allotment basis. The payment date is October 20, 2020. The transaction has been approved by the board of directors of the company. 
